Simplex Trading
BTTX

Simplex Trading’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Simplex Trading’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,300
Closed -$21K – 10252
2023
Q1 		$21K Buy
30,300
+600
+2% +$705 ﹤0.01% 6892
2022
Q4 		$32K Sell
29,700
-5,600
-16% -$8.26K ﹤0.01% 6405
2022
Q3 		$62K Buy
35,300
+4,400
+14% +$8.03K ﹤0.01% 6150
2022
Q2 		$48K Buy
+30,900
New +$51.7K ﹤0.01% 6567

Other funds holding BTTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Simplex Trading's BTTX Position: Q1 2022 in Review

Simplex Trading sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2022, closing a stake of 94 shares — an estimated $325 sold.

Simplex Trading first reported a position in BTTX in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 14 funds tracked by Wall St. Rank hold BTTX as of Q1 2022.

  • Simplex Trading reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Simplex Trading sold 94 Better Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $325.
  • Simplex Trading first reported a position in Better Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Simplex Trading's Better Therapeutics, Inc. Common Stock position peaked at $0 in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.